Walgreens reaches $83M opioid settlement with West Virginia
BCFC/iStock Editorial via Getty Images


West Virginia has reached an $83M settlement with Walgreens Boots Alliance (NASDAQ:WBA) over the pharmacy chain's role in the opioid crisis, the state's Attorney General Patrick Morrisey announced Wednesday.
Morrisey said that Walgreens (WBA) has agreed to pay the amount over eight years, resolving a lawsuit that alleged the company, through its failure to maintain adequate controls, contributed to the oversupply of opioids in the state.

"We will continue to seek out justice for those affected the most by the opioid epidemic that hit our state the hardest," Morrisey said.
"This and other settlements will not bring back the lives lost from the opioid menace, but our hope is that the money would provide significant help to those affected the most by this crisis in West Virginia."
The settlement is part of a larger trial involving other major pharmacy operators, including Kroger (KR), which stands as the last remaining defendant, ahead of a trial set for June.
In September, CVS (CVS) and Walmart (WMT) agreed to pay ~$65.1M and $82.5M to settle their opioid-related charges in the state, respectively.